The Effect of Ergothioneine Supplementation on Cognitive Function, Memory, and Sleep in Older Adults with Subjective Memory Complaints: A Randomized Placebo-Controlled Trial
Nutraceuticals · 27.06.2025 · 5 (3) · 15
DOI: 10.3390/nutraceuticals5030015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutraceuticals, online erschienen am 27.06.2025. Verfasst von Ian T. Zajac und 3 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Phyto Tech Corp (d/b/a Blue California).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Ergothioneine is a diet-derived antioxidant with emerging evidence of neuroprotective benefits, but no dose-ranging study has evaluated its effects in healthy older adults. In this 16-week randomized, double-blind, placebo-controlled trial, 147 adults aged 55–79 with subjective memory complaints received ergothioneine (10 mg or 25 mg/day ErgoActive®) or placebo. The primary outcome was the change in composite memory (CNS Vital Signs). Secondary outcomes included other cognitive domains, subjective memory and sleep quality, and blood biomarkers. At baseline, participants showed slightly above-average cognitive function (neurocognitive index median = 105), with plasma ergothioneine levels of median = 1154 nM (interquartile range = 889.9). Plasma ergothioneine increased by ~3- and ~6-fold for 10 mg, and ~6- and ~16-fold for 25 mg, at weeks 4 and 16, respectively (p < 0.001). 25 mg ergothioneine showed a within-group improvement in composite memory at week 4 (p < 0.05), although this was not sustained. Reaction time improved in both groups, dependent on time. Other domains showed null or limited effects. Subjective prospective memory and sleep initiation improved dose-dependently, with significant effects at 25 mg (p < 0.05). Liver function improved and a within-group increase in telomere length was noted. In conclusion, ergothioneine supplementation was safe and well tolerated, with evidence suggesting some benefits in this cohort of healthy older adults. Longer trials in individuals with lower baseline ergothioneine or cognitive function are warranted.
Förderung
- Phyto Tech Corp (d/b/a Blue California)
Zitieren
APA
Zajac, I. T., Kakoschke, N., Kuhn-Sherlock, B., & May-Zhang, L. S. (2025). The Effect of Ergothioneine Supplementation on Cognitive Function, Memory, and Sleep in Older Adults with Subjective Memory Complaints: A Randomized Placebo-Controlled Trial. Nutraceuticals, 5(3), 15. https://doi.org/10.3390/nutraceuticals5030015
Vancouver
Zajac IT, Kakoschke N, Kuhn-Sherlock B, May-Zhang LS. The Effect of Ergothioneine Supplementation on Cognitive Function, Memory, and Sleep in Older Adults with Subjective Memory Complaints: A Randomized Placebo-Controlled Trial. Nutraceuticals. 2025;5(3):15. doi:10.3390/nutraceuticals5030015
BibTeX
@article{Zajac2025,
author = {Zajac, Ian T. and Kakoschke, Naomi and Kuhn-Sherlock, Barbara and May-Zhang, Linda S.},
title = {The Effect of Ergothioneine Supplementation on Cognitive Function, Memory, and Sleep in Older Adults with Subjective Memory Complaints: A Randomized Placebo-Controlled Trial},
journal = {Nutraceuticals},
year = {2025},
volume = {5},
number = {3},
pages = {15},
doi = {10.3390/nutraceuticals5030015}
}
EUVIMED